‹All articles

Sam's story: 1 pill of finasteride

Sam took finasteride for hair loss. In a Moral Medicine interview, he talks about side effects that stayed with him after he stopped the drug.

Sam took finasteride for hair loss. His side effects began while he was on it, and they didn’t end when he stopped. Symptoms that last like this are called post-finasteride syndrome (PFS).

If something changed for you after finasteride and hasn’t gone away, his account may sound familiar.

Sam tells his story in his own words, in the Moral Medicine video at the top of this page. It runs for about 35 minutes.

What do the regulators say about this, and what can you do?

What is post-finasteride syndrome?

It is the name for symptoms that carry on after someone stops finasteride. In 2024 the UK medicines regulator, the MHRA, reminded doctors that sexual problems have sometimes continued after the last tablet. It also linked the drug to depression and suicidal thoughts.

PFS is more than sexual problems. Diagnostic criteria proposed in 2022 also list problems with cognition and depression, which can happen without any sexual problems. Nobody has measured how often PFS happens.

What can you do if this sounds familiar?

If you feel depressed or have suicidal thoughts, the MHRA’s advice is to stop the 1 mg tablet straight away and contact your doctor. Anything else is a decision for you and your prescriber.

If you are struggling right now, you can call Samaritans free on 116 123, day or night.

You can also report what happened. A report to the medicines regulator is how patterns get noticed, and no proof is needed. In the UK use the Yellow Card scheme, in the US MedWatch. If symptoms continued after stopping, write Post 5-alpha-reductase inhibitor syndrome (MedDRA 10082430). Our reporting guide walks you through it.

Thank you to Sam for telling his story. The interview was recorded by Moral Medicine, and you can watch more of their conversations on the Moral Medicine YouTube channel.

Sources

  • MHRA. Finasteride: reminder of the risk of psychiatric side effects and of sexual side effects (which may persist after discontinuation of treatment). Drug Safety Update, 29 April 2024. gov.uk
  • Healy D, et al. Diagnostic criteria for enduring sexual dysfunction after treatment with antidepressants, finasteride and isotretinoin. Int J Risk Saf Med. 2022;33(1):65-76. PubMed 34719438
  • MHRA. Yellow Card scheme. yellowcard.mhra.gov.uk
  • Moral Medicine. Interview with Sam on post-finasteride syndrome. YouTube, 5 July 2023. youtube.com

If this is your story and you would rather it was not here, write to contact@sidefxhub.com. We will take the page down within 48 hours, and you do not have to tell us why.

By Morten SkovPublished Updated

SIDEfxHUB is a patient charity. We are not health professionals, and this does not replace medical advice. Don't start, stop or change any medicine because of what you read here. Talk to your doctor first.

If you are in crisis:116 123 Samaritans (UK)988 Lifeline (US)Find a helpline

SIDEfxHUB Registry

640+ people have joined the registry.
Join them, then report your side effects.

Free. Sign up takes 2 minutes.

Live 640+ people counted so far Each dot is one person 62countries 3conditions